<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2024//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_240101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Curated"><PMID Version="1">35040013</PMID><DateCompleted><Year>2022</Year><Month>04</Month><Day>20</Day></DateCompleted><DateRevised><Year>2022</Year><Month>10</Month><Day>06</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1573-2592</ISSN><JournalIssue CitedMedium="Internet"><Volume>42</Volume><Issue>3</Issue><PubDate><Year>2022</Year><Month>Apr</Month></PubDate></JournalIssue><Title>Journal of clinical immunology</Title><ISOAbbreviation>J Clin Immunol</ISOAbbreviation></Journal><ArticleTitle>Life-Threatening Enterovirus 71 Encephalitis in Unrelated Children with Autosomal Dominant TLR3 Deficiency.</ArticleTitle><Pagination><StartPage>606</StartPage><EndPage>617</EndPage><MedlinePgn>606-617</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1007/s10875-021-01170-9</ELocationID><Abstract><AbstractText Label="PURPOSE">Enterovirus A71 (EV71) causes a broad spectrum of childhood diseases, ranging from asymptomatic infection or self-limited hand-foot-and-mouth disease (HFMD) to life-threatening encephalitis. The molecular mechanisms underlying these different clinical presentations remain unknown. We hypothesized that EV71 encephalitis in children might reflect an intrinsic host single-gene defect of antiviral immunity. We searched for mutations in the toll-like receptor 3 (TLR3) gene. Such mutations have already been identified in children with herpes simplex virus encephalitis (HSE).</AbstractText><AbstractText Label="METHODS">We sequenced TLR3 and assessed the impact of the mutations identified. We tested dermal fibroblasts from a patient with EV71 encephalitis and a&#xa0;TLR3 mutation and other patients with known genetic defects of TLR3 or related genes, assessing the response of these cells to TLR3 agonist poly(I:C) stimulation and EV71 infection.</AbstractText><AbstractText Label="RESULTS">Three children with EV71 encephalitis were heterozygous for rare mutations-TLR3 W769X, E211K, and R867Q-all of which were shown to affect TLR3 function. Furthermore, fibroblasts from the patient heterozygous for the W769X mutation displayed an impaired, but not abolished, response to poly(I:C). We found that TLR3-deficient and TLR3-heterozygous W769X fibroblasts were highly susceptible to EV71 infection.</AbstractText><AbstractText Label="CONCLUSIONS">Autosomal dominant TLR3 deficiency may underlie severe EV71 infection with encephalitis. Human TLR3 immunity is essential to protect the central nervous system against HSV-1 and EV71. Children with severe EV71 infections, such as encephalitis in particular, should be tested for inborn errors of TLR3 immunity.</AbstractText><CopyrightInformation>&#xa9; 2021. The Author(s), under exclusive licence to Springer Science+Business Media, LLC, part of Springer Nature.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Kuo</LastName><ForeName>Chen-Yen</ForeName><Initials>CY</Initials><AffiliationInfo><Affiliation>Laboratory of Human Immunology and Infectious Diseases, Graduate Institute of Clinical Medical Sciences, Chang Gung University, No. 259 Wen-Hwa 1st Road, Kwei-Shan 333, Taoyuan, Taiwan.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Division of Infectious Diseases, Department of Pediatrics, Linkou Chang Gung Memorial Hospital, No. 5, Fu-Shin St, Kwei-Shan 333, Taoyuan, Taiwan.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>College of Medicine, Chang Gung University, Taoyuan, Taiwan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y" EqualContrib="Y"><LastName>Ku</LastName><ForeName>Cheng-Lung</ForeName><Initials>CL</Initials><Identifier Source="ORCID">0000-0002-0643-2256</Identifier><AffiliationInfo><Affiliation>Laboratory of Human Immunology and Infectious Diseases, Graduate Institute of Clinical Medical Sciences, Chang Gung University, No. 259 Wen-Hwa 1st Road, Kwei-Shan 333, Taoyuan, Taiwan. clku@cgu.edu.tw.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Center for Molecular and Clinical Immunology, Chang Gung University, Taoyuan, Taiwan. clku@cgu.edu.tw.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Nephrology, Linkou Chang Gung Memorial Hospital, Taoyuan, Taiwan. clku@cgu.edu.tw.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lim</LastName><ForeName>Hye-Kyung</ForeName><Initials>HK</Initials><AffiliationInfo><Affiliation>St. Giles Laboratory of Human Genetics of Infectious Diseases, Rockefeller Branch, The Rockefeller University, New York, NY, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Laboratory of Human Genetics of Infectious Diseases, Necker Branch, Necker Hospital for Sick Children, Paris, France.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Imagine Institute, Paris Descartes University, Paris, France.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Hsia</LastName><ForeName>Shao-Hsuan</ForeName><Initials>SH</Initials><AffiliationInfo><Affiliation>Division of Pediatric Critical Care Medicine, Linkou Chang Gung Memorial Hospital, Taoyuan, Taiwan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lin</LastName><ForeName>Jainn-Jim</ForeName><Initials>JJ</Initials><AffiliationInfo><Affiliation>Division of Pediatric Critical Care Medicine, Linkou Chang Gung Memorial Hospital, Taoyuan, Taiwan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lo</LastName><ForeName>Chia-Chi</ForeName><Initials>CC</Initials><AffiliationInfo><Affiliation>Laboratory of Human Immunology and Infectious Diseases, Graduate Institute of Clinical Medical Sciences, Chang Gung University, No. 259 Wen-Hwa 1st Road, Kwei-Shan 333, Taoyuan, Taiwan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ding</LastName><ForeName>Jing-Ya</ForeName><Initials>JY</Initials><AffiliationInfo><Affiliation>Laboratory of Human Immunology and Infectious Diseases, Graduate Institute of Clinical Medical Sciences, Chang Gung University, No. 259 Wen-Hwa 1st Road, Kwei-Shan 333, Taoyuan, Taiwan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kuo</LastName><ForeName>Rei-Lin</ForeName><Initials>RL</Initials><AffiliationInfo><Affiliation>Department of Medical Biotechnology and Laboratory Science, Chang Gung University, Taoyuan, Taiwan.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Research Center for Emerging Viral Infections, Chang Gung University, Taoyuan, Taiwan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Casanova</LastName><ForeName>Jean-Laurent</ForeName><Initials>JL</Initials><AffiliationInfo><Affiliation>St. Giles Laboratory of Human Genetics of Infectious Diseases, Rockefeller Branch, The Rockefeller University, New York, NY, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Laboratory of Human Genetics of Infectious Diseases, Necker Branch, Necker Hospital for Sick Children, Paris, France.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Imagine Institute, Paris Descartes University, Paris, France.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Howard Hughes Medical Institute, New York, NY, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Pediatric Immuno-Hematology Unit, Necker Hospital, AP-HP, Necker Hospital for Sick Children, Paris, France.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zhang</LastName><ForeName>Shen-Ying</ForeName><Initials>SY</Initials><AffiliationInfo><Affiliation>St. Giles Laboratory of Human Genetics of Infectious Diseases, Rockefeller Branch, The Rockefeller University, New York, NY, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Laboratory of Human Genetics of Infectious Diseases, Necker Branch, Necker Hospital for Sick Children, Paris, France.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Imagine Institute, Paris Descartes University, Paris, France.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y" EqualContrib="Y"><LastName>Chang</LastName><ForeName>Luan-Yin</ForeName><Initials>LY</Initials><AffiliationInfo><Affiliation>Department of Pediatrics, National Taiwan University Hospital, 7, Chung-Shan South Road, Taipei, 100, Taiwan. lychang@ntu.edu.tw.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y" EqualContrib="Y"><LastName>Lin</LastName><ForeName>Tzou-Yien</ForeName><Initials>TY</Initials><AffiliationInfo><Affiliation>Division of Infectious Diseases, Department of Pediatrics, Linkou Chang Gung Memorial Hospital, No. 5, Fu-Shin St, Kwei-Shan 333, Taoyuan, Taiwan. pidlin@cgmh.org.tw.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>College of Medicine, Chang Gung University, Taoyuan, Taiwan. pidlin@cgmh.org.tw.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>CMRPG3F1211</GrantID><Agency>Chang Gung Memorial Hospital, Linkou</Agency><Country/></Grant><Grant><GrantID>CMRPD190621</GrantID><Agency>Chang Gung Memorial Hospital, Linkou</Agency><Country/></Grant><Grant><GrantID>1A0681</GrantID><Agency>Chang Gung Memorial Hospital, Linkou</Agency><Country/></Grant><Grant><GrantID>NSC-98-2320-B-182-040-MY2</GrantID><Agency>National Science Council</Agency><Country/></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2022</Year><Month>01</Month><Day>18</Day></ArticleDate></Article><MedlineJournalInfo><Country>Netherlands</Country><MedlineTA>J Clin Immunol</MedlineTA><NlmUniqueID>8102137</NlmUniqueID><ISSNLinking>0271-9142</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="C495344">TLR3 protein, human</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D051196">Toll-Like Receptor 3</NameOfSubstance></Chemical><Chemical><RegistryNumber>O84C90HH2L</RegistryNumber><NameOfSubstance UI="D011070">Poly I-C</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><CommentsCorrectionsList><CommentsCorrections RefType="ErratumIn"><RefSource>J Clin Immunol. 2022 Aug;42(6):1347. doi: 10.1007/s10875-022-01259-9</RefSource><PMID Version="1">35403943</PMID></CommentsCorrections></CommentsCorrectionsList><MeshHeadingList><MeshHeading><DescriptorName UI="D002478" MajorTopicYN="N">Cells, Cultured</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D002648" MajorTopicYN="N">Child</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D020803" MajorTopicYN="Y">Encephalitis, Herpes Simplex</DescriptorName><QualifierName UI="Q000175" MajorTopicYN="N">diagnosis</QualifierName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D018792" MajorTopicYN="Y">Encephalitis, Viral</DescriptorName><QualifierName UI="Q000175" MajorTopicYN="N">diagnosis</QualifierName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D004770" MajorTopicYN="Y">Enterovirus</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D029821" MajorTopicYN="Y">Enterovirus A, Human</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D004769" MajorTopicYN="Y">Enterovirus Infections</DescriptorName><QualifierName UI="Q000175" MajorTopicYN="N">diagnosis</QualifierName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011070" MajorTopicYN="N">Poly I-C</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D051196" MajorTopicYN="N">Toll-Like Receptor 3</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Encephalitis</Keyword><Keyword MajorTopicYN="N">Enterovirus 71</Keyword><Keyword MajorTopicYN="N">Inborn error of immunity</Keyword><Keyword MajorTopicYN="N">Toll-like receptor 3</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2020</Year><Month>8</Month><Day>5</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2021</Year><Month>11</Month><Day>1</Day></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2022</Year><Month>1</Month><Day>19</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2022</Year><Month>4</Month><Day>21</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2022</Year><Month>1</Month><Day>18</Day><Hour>6</Hour><Minute>9</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">35040013</ArticleId><ArticleId IdType="doi">10.1007/s10875-021-01170-9</ArticleId><ArticleId IdType="pii">10.1007/s10875-021-01170-9</ArticleId></ArticleIdList><ReferenceList><Title>References</Title><Reference><Citation>Jacques J, Moret H, Minette D, Leveque N, Jovenin N, Deslee G, Lebargy F, Motte J, Andreoletti L. Epidemiological, molecular, and clinical features of enterovirus respiratory infections in French children between 1999 and 2005. J Clin Microbiol. 2008;46(1):206&#x2013;13.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/JCM.01414-07</ArticleId><ArticleId IdType="pubmed">18003804</ArticleId></ArticleIdList></Reference><Reference><Citation>Ho M, Chen ER, Hsu KH, Twu SJ, Chen KT, Tsai SF, Wang JR, Shih SR. An epidemic of enterovirus 71 infection in Taiwan. Taiwan Enterovirus Epidemic Working Group. N Engl J Med. 1999;341(13):929&#x2013;35.</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJM199909233411301</ArticleId><ArticleId IdType="pubmed">10498487</ArticleId></ArticleIdList></Reference><Reference><Citation>Chang LY. Enterovirus 71 in Taiwan. Pediatr Neonatol. 2008;49(4):103&#x2013;12.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S1875-9572(08)60023-6</ArticleId><ArticleId IdType="pubmed">19054914</ArticleId></ArticleIdList></Reference><Reference><Citation>Huang CC, Liu CC, Chang YC, Chen CY, Wang ST, Yeh TF. Neurologic complications in children with enterovirus 71 infection. N Engl J Med. 1999;341(13):936&#x2013;42.</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJM199909233411302</ArticleId><ArticleId IdType="pubmed">10498488</ArticleId></ArticleIdList></Reference><Reference><Citation>Chang LY, Lin HY, Gau SS, Lu CY, Hsia SH, Huang YC, et al. Enterovirus A71 neurologic complications and long-term sequelae. J Biomed Sci. 2019;26(1):57.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12929-019-0552-7</ArticleId><ArticleId IdType="pubmed">31395054</ArticleId><ArticleId IdType="pmc">6688366</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang SY, Herman M, Ciancanelli MJ. Perez de Diego R, Sancho-Shimizu V, Abel L, Casanova JL: TLR3 immunity to infection in mice and humans. Curr Opin Immunol. 2013;25(1):19&#x2013;33.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.coi.2012.11.001</ArticleId><ArticleId IdType="pubmed">23290562</ArticleId><ArticleId IdType="pmc">3594520</ArticleId></ArticleIdList></Reference><Reference><Citation>Sancho-Shimizu V. Perez de Diego R, Jouanguy E, Zhang SY, Casanova JL: Inborn errors of anti-viral interferon immunity in humans. Curr Opin Virol. 2011;1(6):487&#x2013;96.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.coviro.2011.10.016</ArticleId><ArticleId IdType="pubmed">22347990</ArticleId><ArticleId IdType="pmc">3280408</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang SY, Jouanguy E, Ugolini S, Smahi A, Elain G, Romero P, Segal D, Sancho-Shimizu V, Lorenzo L, Puel A, et al. TLR3 deficiency in patients with herpes simplex encephalitis. Science. 2007;317(5844):1522&#x2013;7.</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/science.1139522</ArticleId><ArticleId IdType="pubmed">17872438</ArticleId></ArticleIdList></Reference><Reference><Citation>Guo Y, Audry M, Ciancanelli M, Alsina L, Azevedo J, Herman M, Anguiano E, Sancho-Shimizu V, Lorenzo L, Pauwels E, et al. Herpes simplex virus encephalitis in a patient with complete TLR3 deficiency: TLR3 is otherwise redundant in protective immunity. J Exp Med. 2011;208(10):2083&#x2013;98.</Citation><ArticleIdList><ArticleId IdType="doi">10.1084/jem.20101568</ArticleId><ArticleId IdType="pubmed">21911422</ArticleId><ArticleId IdType="pmc">3182056</ArticleId></ArticleIdList></Reference><Reference><Citation>Lim HK, Seppanen M, Hautala T, Ciancanelli MJ, Itan Y, Lafaille FG, Dell W, Lorenzo L, Byun M, Pauwels E, et al. TLR3 deficiency in herpes simplex encephalitis: high allelic heterogeneity and recurrence risk. Neurology. 2014;83(21):1888&#x2013;97.</Citation><ArticleIdList><ArticleId IdType="doi">10.1212/WNL.0000000000000999</ArticleId><ArticleId IdType="pubmed">25339207</ArticleId><ArticleId IdType="pmc">4248460</ArticleId></ArticleIdList></Reference><Reference><Citation>Casrouge A, Zhang SY, Eidenschenk C, Jouanguy E, Puel A, Yang K, Alcais A, Picard C, Mahfoufi N, Nicolas N, et al. Herpes simplex virus encephalitis in human UNC-93B deficiency. Science. 2006;314(5797):308&#x2013;12.</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/science.1128346</ArticleId><ArticleId IdType="pubmed">16973841</ArticleId></ArticleIdList></Reference><Reference><Citation>Herman M, Ciancanelli M, Ou YH, Lorenzo L, Klaudel-Dreszler M, Pauwels E, Sancho-Shimizu V, Perez de Diego R, Abhyankar A, Israelsson E, et al. Heterozygous TBK1 mutations impair TLR3 immunity and underlie herpes simplex encephalitis of childhood. J Exp Med. 2012;209(9):1567&#x2013;82.</Citation><ArticleIdList><ArticleId IdType="doi">10.1084/jem.20111316</ArticleId><ArticleId IdType="pubmed">22851595</ArticleId><ArticleId IdType="pmc">3428952</ArticleId></ArticleIdList></Reference><Reference><Citation>Perez de Diego R, Sancho-Shimizu V, Lorenzo L, Puel A, Plancoulaine S, Picard C, Herman M, Cardon A, Durandy A, Bustamante J, et al. Human TRAF3 adaptor molecule deficiency leads to impaired Toll-like receptor 3 response and susceptibility to herpes simplex encephalitis. Immunity. 2010;33(3):400&#x2013;11.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.immuni.2010.08.014</ArticleId><ArticleId IdType="pubmed">20832341</ArticleId></ArticleIdList></Reference><Reference><Citation>Sancho-Shimizu V, Perez de Diego R, Lorenzo L, Halwani R, Alangari A, Israelsson E, Fabrega S, Cardon A, Maluenda J, Tatematsu M, et al. Herpes simplex encephalitis in children with autosomal recessive and dominant TRIF deficiency. J Clin Invest. 2011;121(12):4889&#x2013;902.</Citation><ArticleIdList><ArticleId IdType="doi">10.1172/JCI59259</ArticleId><ArticleId IdType="pubmed">22105173</ArticleId><ArticleId IdType="pmc">3226004</ArticleId></ArticleIdList></Reference><Reference><Citation>Andersen LL, Mork N, Reinert LS, Kofod-Olsen E, Narita R, Jorgensen SE, Skipper KA, Honing K, Gad HH, Ostergaard L, et al. Functional IRF3 deficiency in a patient with herpes simplex encephalitis. J Exp Med. 2015;212(9):1371&#x2013;9.</Citation><ArticleIdList><ArticleId IdType="doi">10.1084/jem.20142274</ArticleId><ArticleId IdType="pubmed">26216125</ArticleId><ArticleId IdType="pmc">4548062</ArticleId></ArticleIdList></Reference><Reference><Citation>Gorbea C, Makar KA, Pauschinger M, Pratt G, Bersola JL, Varela J, David RM, Banks L, Huang CH, Li H, et al. A role for Toll-like receptor 3 variants in host susceptibility to enteroviral myocarditis and dilated cardiomyopathy. J Biol Chem. 2010;285(30):23208&#x2013;23.</Citation><ArticleIdList><ArticleId IdType="doi">10.1074/jbc.M109.047464</ArticleId><ArticleId IdType="pubmed">20472559</ArticleId><ArticleId IdType="pmc">2906314</ArticleId></ArticleIdList></Reference><Reference><Citation>Belkaya S, Kontorovich AR, Byun M, Mulero-Navarro S, Bajolle F, Cobat A, Josowitz R, Itan Y, Quint R, Lorenzo L, et al. Autosomal recessive cardiomyopathy presenting as acute myocarditis. J Am Coll Cardiol. 2017;69(13):1653&#x2013;65.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jacc.2017.01.043</ArticleId><ArticleId IdType="pubmed">28359509</ArticleId><ArticleId IdType="pmc">5551973</ArticleId></ArticleIdList></Reference><Reference><Citation>Lim HK, Huang SXL, Chen J, Kerner G, Gilliaux O, Bastard P, Dobbs K, Hernandez N, Goudin N, Hasek ML, et al. Severe influenza pneumonitis in children with inherited TLR3 deficiency. J Exp Med. 2019;216(9):2038&#x2013;56.</Citation><ArticleIdList><ArticleId IdType="doi">10.1084/jem.20181621</ArticleId><ArticleId IdType="pubmed">31217193</ArticleId><ArticleId IdType="pmc">6719423</ArticleId></ArticleIdList></Reference><Reference><Citation>Sun Y, Leaman DW. Ectopic expression of Toll-like receptor-3 (TLR-3) overcomes the double-stranded RNA (dsRNA) signaling defects of P2.1 cells. J Interferon Cytokine Res. 2004;24(6):350&#x2013;61.</Citation><ArticleIdList><ArticleId IdType="doi">10.1089/107999004323142213</ArticleId><ArticleId IdType="pubmed">15212709</ArticleId></ArticleIdList></Reference><Reference><Citation>Stojdl DF, Lichty BD, tenOever BR, Paterson JM, Power AT, Knowles S, Marius R, Reynard J, Poliquin L, Atkins H, et al. VSV strains with defects in their ability to shutdown innate immunity are potent systemic anti-cancer agents. Cancer Cell. 2003;4(4):263&#x2013;75.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S1535-6108(03)00241-1</ArticleId><ArticleId IdType="pubmed">14585354</ArticleId></ArticleIdList></Reference><Reference><Citation>Oshiumi H, Matsumoto M, Funami K, Akazawa T, Seya T. TICAM-1, an adaptor molecule that participates in Toll-like receptor 3-mediated interferon-beta induction. Nat Immunol. 2003;4(2):161&#x2013;7.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/ni886</ArticleId><ArticleId IdType="pubmed">12539043</ArticleId></ArticleIdList></Reference><Reference><Citation>Garcia-Cattaneo A, Gobert FX, Muller M, Toscano F, Flores M, Lescure A, Del Nery E, Benaroch P. Cleavage of toll-like receptor 3 by cathepsins B and H is essential for signaling. Proc Natl Acad Sci USA. 2012;109(23):9053&#x2013;8.</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.1115091109</ArticleId><ArticleId IdType="pubmed">22611194</ArticleId><ArticleId IdType="pmc">3384196</ArticleId></ArticleIdList></Reference><Reference><Citation>Sironi M, Peri AM, Cagliani R, Forni D, Riva S, Biasin M, et al. TLR3 mutations in adult patients with herpes simplex virus and varicella-zoster virus encephalitis. J Infect Dis. 2017;215(9):1430&#x2013;4.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/infdis/jix166</ArticleId><ArticleId IdType="pubmed">28368532</ArticleId></ArticleIdList></Reference><Reference><Citation>Liang F, Glans H, Enoksson SL, Kolios AGA, Lore K, Nilsson J. Recurrent herpes zoster ophthalmicus in a patient with a novel Toll-like receptor 3 variant linked to compromised activation capacity in fibroblasts. J Infect Dis. 2020;221(8):1295&#x2013;303.</Citation><ArticleIdList><ArticleId IdType="pubmed">31268141</ArticleId></ArticleIdList></Reference><Reference><Citation>McMinn PC. Recent advances in the molecular epidemiology and control of human enterovirus 71 infection. Curr Opin Virol. 2012;2(2):199&#x2013;205.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.coviro.2012.02.009</ArticleId><ArticleId IdType="pubmed">22482716</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang X, Xu H, Chen X, Li X, Wang X, Ding S, Zhang R, Liu L, He C, Zhuang L, et al. Association of functional polymorphisms in the MxA gene with susceptibility to enterovirus 71 infection. Hum Genet. 2014;133(2):187&#x2013;97.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00439-013-1367-3</ArticleId><ArticleId IdType="pubmed">24085612</ArticleId></ArticleIdList></Reference><Reference><Citation>Chang LY, Chang IS, Chen WJ, Huang YC, Chen GW, Shih SR, Juang JL, Shih HM, Hsiung CA, Lin TY, et al. HLA-A33 is associated with susceptibility to enterovirus 71 infection. Pediatrics. 2008;122(6):1271&#x2013;6.</Citation><ArticleIdList><ArticleId IdType="doi">10.1542/peds.2007-3735</ArticleId><ArticleId IdType="pubmed">19047245</ArticleId></ArticleIdList></Reference><Reference><Citation>Yang J, Zhao N, Su NL, Sun JL, Lv TG, Chen ZB. Association of interleukin 10 and interferon gamma gene polymorphisms with enterovirus 71 encephalitis in patients with hand, foot and mouth disease. Scand J Infect Dis. 2012;44(6):465&#x2013;9.</Citation><ArticleIdList><ArticleId IdType="doi">10.3109/00365548.2011.649490</ArticleId><ArticleId IdType="pubmed">22263663</ArticleId></ArticleIdList></Reference><Reference><Citation>Chopra JS, Sawhney IMS, Dhand UK, Prabhakar S, Naik S, Sehgal&#xa0;S. Neurological complications of acute haemorrhagic conjunctivitis. J Neurol Sci. 1986;73(2):177&#x2013;91.</Citation></Reference><Reference><Citation>Casanova JL, Abel L. The genetic theory of infectious diseases: a brief history and selected illustrations. Annu Rev Genomics Hum Genet. 2013;14:215&#x2013;43.</Citation><ArticleIdList><ArticleId IdType="doi">10.1146/annurev-genom-091212-153448</ArticleId><ArticleId IdType="pubmed">23724903</ArticleId><ArticleId IdType="pmc">4980761</ArticleId></ArticleIdList></Reference><Reference><Citation>Bsibsi M, Ravid R, Gveric D, van Noort JM. Broad expression of toll-like receptors in the human central nervous system. J Neuropath Exp Neurol. 2002;61(11):1013&#x2013;21.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/jnen/61.11.1013</ArticleId><ArticleId IdType="pubmed">12430718</ArticleId></ArticleIdList></Reference><Reference><Citation>Chang SC, Lin JY, Lo LY, Li ML, Shih SR. Diverse apoptotic pathways in enterovirus 71-infected cells. J Neurovirol. 2004;10(6):338&#x2013;49.</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/13550280490521032</ArticleId><ArticleId IdType="pubmed">15765805</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang YF, Chou CT, Lei HY, Liu CC, Wang SM, Yan JJ, Su IJ, Wang JR, Yeh TM, Chen SH, et al. A mouse-adapted enterovirus 71 strain causes neurological disease in mice after oral infection. J Virol. 2004;78(15):7916&#x2013;24.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/JVI.78.15.7916-7924.2004</ArticleId><ArticleId IdType="pubmed">15254164</ArticleId><ArticleId IdType="pmc">446098</ArticleId></ArticleIdList></Reference><Reference><Citation>Lafaille FG, Pessach IM, Zhang SY, Ciancanelli MJ, Herman M, Abhyankar A, Ying SW, Keros S, Goldstein PA, Mostoslavsky G, et al. Impaired intrinsic immunity to HSV-1 in human iPSC-derived TLR3-deficient CNS cells. Nature. 2012;491(7426):769&#x2013;73.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nature11583</ArticleId><ArticleId IdType="pubmed">23103873</ArticleId><ArticleId IdType="pmc">3527075</ArticleId></ArticleIdList></Reference><Reference><Citation>Lafaille FG, Ciancanelli MJ, Studer L, Smith G, Notarangelo L, Casanova JL, Zhang SY. Deciphering human cell-autonomous anti-HSV-1 immunity in the central nervous system. Front Immunol. 2015;6:208.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fimmu.2015.00208</ArticleId><ArticleId IdType="pubmed">26005444</ArticleId><ArticleId IdType="pmc">4424875</ArticleId></ArticleIdList></Reference><Reference><Citation>Kuo RL, Kao LT, Lin SJ, Wang RY, Shih SR. MDA5 plays a crucial role in enterovirus 71 RNA-mediated IRF3 activation. PLoS One. 2013;8(5):e63431.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0063431</ArticleId><ArticleId IdType="pubmed">23650567</ArticleId><ArticleId IdType="pmc">3641126</ArticleId></ArticleIdList></Reference><Reference><Citation>Lei X, Xiao X, Xue Q, Jin Q, He B, Wang J. Cleavage of interferon regulatory factor 7 by enterovirus 71 3C suppresses cellular responses. J Virol. 2013;87(3):1690&#x2013;8.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/JVI.01855-12</ArticleId><ArticleId IdType="pubmed">23175366</ArticleId><ArticleId IdType="pmc">3554134</ArticleId></ArticleIdList></Reference><Reference><Citation>Lu J, Yi L, Zhao J, Yu J, Chen Y, Lin MC, Kung HF, He ML. Enterovirus 71 disrupts interferon signaling by reducing the level of interferon receptor 1. J Virol. 2012;86(7):3767&#x2013;76.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/JVI.06687-11</ArticleId><ArticleId IdType="pubmed">22258259</ArticleId><ArticleId IdType="pmc">3302529</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang B, Xi X, Lei X, Zhang X, Cui S, Wang J, Jin Q, Zhao Z. Enterovirus 71 protease 2Apro targets MAVS to inhibit anti-viral type I interferon responses. PLoS Pathog. 2013;9(3):e1003231.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.ppat.1003231</ArticleId><ArticleId IdType="pubmed">23555247</ArticleId><ArticleId IdType="pmc">3605153</ArticleId></ArticleIdList></Reference><Reference><Citation>Negishi H, Osawa T, Ogami K, Ouyang X, Sakaguchi S, Koshiba R, Yanai H, Seko Y, Shitara H, Bishop K, et al. A critical link between toll-like receptor 3 and type II interferon signaling pathways in antiviral innate immunity. Proc Natl Acad Sci USA. 2008;105(51):20446&#x2013;51.</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.0810372105</ArticleId><ArticleId IdType="pubmed">19074283</ArticleId><ArticleId IdType="pmc">2629334</ArticleId></ArticleIdList></Reference><Reference><Citation>Lei X, Sun Z, Liu X, Jin Q, He B, Wang J. Cleavage of the adaptor protein TRIF by enterovirus 71 3C inhibits antiviral responses mediated by Toll-like receptor 3. J Virol. 2011;85(17):8811&#x2013;8.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/JVI.00447-11</ArticleId><ArticleId IdType="pubmed">21697485</ArticleId><ArticleId IdType="pmc">3165803</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>